ARS Pharmaceuticals, Inc. (SPRY)

SEC filing

ARS Pharmaceuticals, Inc.

SPRY · CIK 1671858

4 · Sep 2, 2026 · Chief Commercial Officer Smith Margaret Ekins was granted 1.00M Stock Option (right to buy)

Chief Commercial Officer Smith Margaret Ekins was granted 1.00M Stock Option (right to buy)

xslF345X06/form4-09022026_090920.xml

xslF345X06/form4-09022026_090920.xmlSEC.gov

Graphics and non-inline formats (not embedded below).